At scPharmaceuticals, we believe the benefits of moving care from in- to outpatient settings extend well beyond improved outcomes and reduced risks. A higher quality of life for patients, lower healthcare costs, and the potential for many patients to manage their own care are just a few of the advantages. We aim to break the cycle in acute care management by examining existing treatment paradigms and propelling new treatment options forward to deliver efficient and effective methods of outpatient care.
Location: United States, Illinois
Employees: 11-50
Phone: +1 617-517-0730
Total raised: $111.6M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 22.11.2022 | - | $50M | - |
| 04.01.2017 | Series B | $45.6M | OrbiMed |
| 26.03.2014 | Series A | $16M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 13.03.2024 | scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year ... | - | globenewsw... |
| 06.03.2024 | scPharmaceuticals to Announce Fourth Quarter and Full-Year 2... | - | globenewsw... |
| 22.11.2022 | scPharmaceuticals Announces Pricing of $50 Million Public Of... | - | orbimed.co... |
| 17.11.2017 | Term Sheet — Friday, November 17 | THE ULTIMATE BUSINESS BOOK LIST Good morning, Term Sheet readers. Paid Content How can you protect w... | fortune.co... |
| 07.11.2017 | Term Sheet — Tuesday, November 7 | THE LITTLE PINK PILL Good morning, Term Sheet readers. Paid Content You can't secure what you can't ... | fortune.co... |
| 24.10.2017 | Term Sheet — Tuesday, October 24 | THREE THINGS Good morning, Term Sheet readers. Paid Content A.I. is the answer to protecting your en... | fortune.co... |
| 04.01.2017 | scPharmaceuticals Closes $45.6M Series B Funding Round | scPharmaceuticals, a Lexington, Mass.-based biopharmaceutical company developing pharmaceutical prod... | finsmes.co... |
| 04.01.2017 | scPharmaceuticals Raises $45.6 Million Series B, Co-led by O... | scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharma... | citybizlis... |
| 30.05.2016 | 5AM Ventures has raised $285M for fifth fund (Updated) | Update On Monday, it confirmed the amount in a press release on its website. In a phone interview wi... | medcitynew... |
| 05.02.2016 | scPharmaceuticals’ drug/device combo aims at replacing IVs i... | The company is developing a new drug delivery method for both heart failure and infectious disease –... | medcitynew... |
Show more